Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The awardees for the second round of the University of Oxford’s Enriching Engagement funding scheme have now been announced, including six projects from across the Medical Sciences Division.

Enriching Engagement is a Wellcome-funded grants programme open to Wellcome grant holders and awardees at the University of Oxford, to develop and deliver Public Engagement with Research projects. 

Round 2 awardees are:

  1. Dr Catherine Manning (Department of Experimental Psychology) -  "Sensory Street”
  2. Dr Jacinta O’Shea (Department of Psychiatry) - "Building stress resilience in early adolescence”
  3. Professor Anne Goriely (Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine) - “Me and my genome: What am I really made of?”
  4. Dr Carlo Rinaldi (Department of Paediatrics) - "Muscle Switch"
  5. Professor Jane Mckeating (Nuffield Department of Medicine) - "Understanding viruses: combining science and art to empower young people”
  6. Dr Anna Mitchell (Department of Experimental Psychology) - "APE: Animations and Public Engagement to promote transparency in primate neuroscience research”

Full details of each project are available on the University of Oxford website

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.